{"id":"W2797238574","doi":"10.1016/j.jaad.2018.04.013","title":"Certolizumab pegol for the treatment of chronic plaque psoriasis: Results through 48 weeks of a phase 3, multicenter, randomized, double-blind, etanercept- and placebo-controlled study (CIMPACT)","year":2018,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":131,"is_retracted":false,"has_abstract":true,"ca_institutions":"Women's College Hospital; University of Toronto","funders":"","keywords":"Certolizumab pegol; Medicine; Placebo; Etanercept; Psoriasis Area and Severity Index; Clinical endpoint; Psoriasis; Internal medicine; Adverse effect; Randomized controlled trial; Tumor necrosis factor alpha; Dermatology; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005083805,0.001232122,0.002035327,0.0003944818,0.0004909977,0.0008576146,0.0007434995,0.002152466,0.003325668],"category_scores_gemma":[0.002314009,0.0005272208,0.002358324,0.0004443228,0.0008205978,0.0008588093,0.0002817817,0.002773134,0.0006270366],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005648115,"about_ca_system_score_gemma":0.001404888,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000789846,"about_ca_topic_score_gemma":0.00115438,"domain_scores_codex":[0.9989936,0.0005285693,0.00007411154,0.0001436291,0.0001374603,0.0001227306],"domain_scores_gemma":[0.9985145,0.0003199978,0.0004079978,0.0001392493,0.0001400994,0.000478088],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8713192,0.0254476,0.003546783,0.001380438,0.002459302,0.000167909,0.0001920874,0.0006764346,0.0135643,0.0001252404,0.002523717,0.07859704],"study_design_scores_gemma":[0.9270335,0.06262115,0.007684193,0.00006266301,0.0004986405,0.0001157112,0.0000169467,0.0002344105,0.0007316818,0.00006261344,0.0009243448,0.00001412531],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9750209,0.01244595,0.001267644,0.001134339,0.0003000636,0.006273676,0.001728023,0.000216944,0.001612537],"genre_scores_gemma":[0.971504,0.009239775,0.004232753,0.002323973,0.0006178014,0.007094053,0.002650343,0.0000809761,0.002256238],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005083805,"threshold_uncertainty_score":0.02688605,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03753779827924125,"score_gpt":0.345756602853417,"score_spread":0.3082188045741758,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}